Persistent peripheral nervous system damage in simian immunodeficiency virus-infected macaques receiving antiretroviral therapy

Jamie L. Dorsey, Lisa Mangus, Peter Hauer, Gigi Ebenezer, Suzanne E. Queen, Victoria A. Laast, Robert John Adams, Joseph L Mankowski

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus (HIV)-induced peripheral neuropathy is the most common neurologic complication associated with HIV infection. In addition to virus-mediated injury of the peripheral nervous system (PNS), treatment of HIV infection with combination antiretroviral therapy (cART) may induce toxic neuropathy as a side effect. Antiretroviral toxic neuropathy is clinically indistinguishable from the sensory neuropathy induced by HIV; in some patients, these 2 processes are likely superimposed. To study these intercurrent PNS disease processes, we first established a simian immunodeficiency virus (SIV)/pigtailed macaque model in which more than 90% of animals developed PNS changes closely resembling those seen in HIV-infected individuals with distal sensory neuropathy. To determine whether cART alters the progression of SIV-induced PNS damage, dorsal root ganglia and epidermal nerve fibers were evaluated in SIV-infected macaques after long-term suppressive cART. Although cART effectively suppressed SIV replication and reduced macrophage activation in the dorsal root ganglia, PGP 9.5 immunostaining and measurements of epidermal nerve fibers in the plantar surface of the feet of treated SIV-infected macaques clearly showed that cART did not normalize epidermal nerve fiber density. These findings illustrate that significant PNS damage persists in SIV-infected macaques on suppressive cART.

Original languageEnglish (US)
Pages (from-to)1053-1060
Number of pages8
JournalJournal of Neuropathology and Experimental Neurology
Volume74
Issue number11
StatePublished - 2015

Fingerprint

Simian Immunodeficiency Virus
Peripheral Nervous System
Macaca
HIV
Nerve Fibers
Poisons
Spinal Ganglia
Peripheral Nervous System Diseases
Virus Diseases
Therapeutics
Macrophage Activation
Virus Replication
Nervous System
Foot
Viruses
Wounds and Injuries

Keywords

  • Antiretroviral therapy
  • Epidermal nerve fibers
  • Human immunodeficiency virus
  • Macaque
  • Neuropathy
  • Simian immunodeficiency virus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Persistent peripheral nervous system damage in simian immunodeficiency virus-infected macaques receiving antiretroviral therapy. / Dorsey, Jamie L.; Mangus, Lisa; Hauer, Peter; Ebenezer, Gigi; Queen, Suzanne E.; Laast, Victoria A.; Adams, Robert John; Mankowski, Joseph L.

In: Journal of Neuropathology and Experimental Neurology, Vol. 74, No. 11, 2015, p. 1053-1060.

Research output: Contribution to journalArticle

@article{689176604bff499a96641c8f01768d90,
title = "Persistent peripheral nervous system damage in simian immunodeficiency virus-infected macaques receiving antiretroviral therapy",
abstract = "Human immunodeficiency virus (HIV)-induced peripheral neuropathy is the most common neurologic complication associated with HIV infection. In addition to virus-mediated injury of the peripheral nervous system (PNS), treatment of HIV infection with combination antiretroviral therapy (cART) may induce toxic neuropathy as a side effect. Antiretroviral toxic neuropathy is clinically indistinguishable from the sensory neuropathy induced by HIV; in some patients, these 2 processes are likely superimposed. To study these intercurrent PNS disease processes, we first established a simian immunodeficiency virus (SIV)/pigtailed macaque model in which more than 90{\%} of animals developed PNS changes closely resembling those seen in HIV-infected individuals with distal sensory neuropathy. To determine whether cART alters the progression of SIV-induced PNS damage, dorsal root ganglia and epidermal nerve fibers were evaluated in SIV-infected macaques after long-term suppressive cART. Although cART effectively suppressed SIV replication and reduced macrophage activation in the dorsal root ganglia, PGP 9.5 immunostaining and measurements of epidermal nerve fibers in the plantar surface of the feet of treated SIV-infected macaques clearly showed that cART did not normalize epidermal nerve fiber density. These findings illustrate that significant PNS damage persists in SIV-infected macaques on suppressive cART.",
keywords = "Antiretroviral therapy, Epidermal nerve fibers, Human immunodeficiency virus, Macaque, Neuropathy, Simian immunodeficiency virus",
author = "Dorsey, {Jamie L.} and Lisa Mangus and Peter Hauer and Gigi Ebenezer and Queen, {Suzanne E.} and Laast, {Victoria A.} and Adams, {Robert John} and Mankowski, {Joseph L}",
year = "2015",
language = "English (US)",
volume = "74",
pages = "1053--1060",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Persistent peripheral nervous system damage in simian immunodeficiency virus-infected macaques receiving antiretroviral therapy

AU - Dorsey, Jamie L.

AU - Mangus, Lisa

AU - Hauer, Peter

AU - Ebenezer, Gigi

AU - Queen, Suzanne E.

AU - Laast, Victoria A.

AU - Adams, Robert John

AU - Mankowski, Joseph L

PY - 2015

Y1 - 2015

N2 - Human immunodeficiency virus (HIV)-induced peripheral neuropathy is the most common neurologic complication associated with HIV infection. In addition to virus-mediated injury of the peripheral nervous system (PNS), treatment of HIV infection with combination antiretroviral therapy (cART) may induce toxic neuropathy as a side effect. Antiretroviral toxic neuropathy is clinically indistinguishable from the sensory neuropathy induced by HIV; in some patients, these 2 processes are likely superimposed. To study these intercurrent PNS disease processes, we first established a simian immunodeficiency virus (SIV)/pigtailed macaque model in which more than 90% of animals developed PNS changes closely resembling those seen in HIV-infected individuals with distal sensory neuropathy. To determine whether cART alters the progression of SIV-induced PNS damage, dorsal root ganglia and epidermal nerve fibers were evaluated in SIV-infected macaques after long-term suppressive cART. Although cART effectively suppressed SIV replication and reduced macrophage activation in the dorsal root ganglia, PGP 9.5 immunostaining and measurements of epidermal nerve fibers in the plantar surface of the feet of treated SIV-infected macaques clearly showed that cART did not normalize epidermal nerve fiber density. These findings illustrate that significant PNS damage persists in SIV-infected macaques on suppressive cART.

AB - Human immunodeficiency virus (HIV)-induced peripheral neuropathy is the most common neurologic complication associated with HIV infection. In addition to virus-mediated injury of the peripheral nervous system (PNS), treatment of HIV infection with combination antiretroviral therapy (cART) may induce toxic neuropathy as a side effect. Antiretroviral toxic neuropathy is clinically indistinguishable from the sensory neuropathy induced by HIV; in some patients, these 2 processes are likely superimposed. To study these intercurrent PNS disease processes, we first established a simian immunodeficiency virus (SIV)/pigtailed macaque model in which more than 90% of animals developed PNS changes closely resembling those seen in HIV-infected individuals with distal sensory neuropathy. To determine whether cART alters the progression of SIV-induced PNS damage, dorsal root ganglia and epidermal nerve fibers were evaluated in SIV-infected macaques after long-term suppressive cART. Although cART effectively suppressed SIV replication and reduced macrophage activation in the dorsal root ganglia, PGP 9.5 immunostaining and measurements of epidermal nerve fibers in the plantar surface of the feet of treated SIV-infected macaques clearly showed that cART did not normalize epidermal nerve fiber density. These findings illustrate that significant PNS damage persists in SIV-infected macaques on suppressive cART.

KW - Antiretroviral therapy

KW - Epidermal nerve fibers

KW - Human immunodeficiency virus

KW - Macaque

KW - Neuropathy

KW - Simian immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=84945186197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945186197&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 1053

EP - 1060

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 11

ER -